NCT05880381

Brief Summary

This study aims to provide psychological support to women that experienced an Early Pregnancy Loss (when the loss occurs until the 20 weeks of gestation) using an innovative Virtual Reality prototype and compare the presence and evolution of psychological distress symptoms pre and post-intervention. The main goals of this study are:

  1. 1.Evaluate the impact of the proposed VR paradigm in women who suffered a gestational loss in the first 20 weeks of gestation, compared to a control group that follows the usual standard care;
  2. 2.Evaluate the usability, user experience, and acceptance of the proposed approach.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

2.2 years

First QC Date

April 17, 2023

Last Update Submit

March 24, 2025

Conditions

Keywords

Virtual RealityPsychological InterventionPersonalization

Outcome Measures

Primary Outcomes (3)

  • Perinatal Grief Scale (PGS)

    Portuguese adaptation of Perinatal Grief Scale- PGS (Rocha, 2004) assesses changes pre and post-intervention, in three subscales that involve perinatal grief symptomatology like active grief, difficulty coping and despair. This scale comprises 33 items divided into three subscales that assess active grief, difficulty coping, and despair. Minimum score of 33 and a maximum 165- higher scores represent more severe grief symptoms.

    Pre-intervention (1 week before the beginning of the intervention) and Post-intervention (4 to 5 weeks after the beginning of the intervention)

  • Posttraumatic Stress Disorder Checklist (PCL-5)

    The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) adapted to the Portuguese population, will be used to evaluate post-intervention changes in post-traumatic stress symptoms. This is a 20-item self-report instrument that assesses the 20 DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) symptoms of PTSD rated from 0 to 4. A minimum score of 0 and a maximum of 80- higher scores represent more severe post-traumatic stress symptoms.

    Pre-intervention (1 week before the beginning of the intervention) and Post-intervention (4 to 5 weeks after the beginning of the intervention)

  • Hospital Anxiety and Depression Scale (HADS)

    HADS is a 14-question instrument that measures anxiety and depression with seven questions for each; each question is scored between zero (no impairment) and three (severe impairment), with a maximum score of 21 for anxiety or depression.

    Pre-intervention (1 week before the beginning of the intervention) and Post-intervention (4 to 5 weeks after the beginning of the intervention)

Secondary Outcomes (3)

  • System Usability Scale (SUS)

    Post-Intervention (4-5 weeks after the beginning of the intervention)

  • Sense of Presence Inventory (ITC)

    Post-Intervention (4-5 weeks after the beginning of the intervention)

  • User Experience questionnaire

    Post-Intervention (4-5 weeks after the beginning of the intervention)

Study Arms (2)

Virtual Reality Group

EXPERIMENTAL

Patients allocated to the treatment group will undergo an intervention that comprises 3 weekly sessions of 60 minutes for 4 weeks with the VR prototype.

Device: Virtual Reality Group

Control Group

OTHER

The participants allocated to this group will do the formal standard care provided by the Gynecology- Obstetric service.

Other: Control Group

Interventions

Patients allocated to the treatment group will undergo an intervention that comprises 3 weekly sessions of 60 minutes for 4 weeks with the VR prototype.

Virtual Reality Group

The participants allocated to this group will do the formal standard care provided by the Gynecology- Obstetric service.

Control Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Women that have experienced an involuntary pregnancy loss in the first 20 weeks in the last 6 months;

You may not qualify if:

  • current pregnancy
  • having a diagnosis of mental disorder,
  • undergoing any psychological intervention,
  • vision impairments that could interfere with the execution of the VR tasks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade da Madeira

Funchal, 9020-105, Portugal

RECRUITING

MeSH Terms

Conditions

Abortion, Spontaneous

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of the two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor and researcher at the University of Madeira

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 30, 2023

Study Start

May 1, 2023

Primary Completion

June 30, 2025

Study Completion

September 30, 2025

Last Updated

March 25, 2025

Record last verified: 2025-03

Locations